Trial Information
Identify Clinical Conditions That Increase Circulating DNA Levels
The investigator will collect 8 mL (one and one half teaspoons) of blood one time only. The
investigator may also collect the patient's past medical history, test results and disease
treatment.
Inclusion Criteria:
1. Patients must be adults in one of the following categories:
- Pregnant
- Suffered a pulmonary embolism within the past 48 hours
- Myocardial infarction in the past 48 hours
- Diagnosed with an autoimmune disease
- Adults age 18-80
- Self-declared healthy adults
2. Patients must be willing to undergo a blood draw
3. Patients must provide study-specific informed consent prior to study entry
Exclusion Criteria:
1. Patients not meeting the above inclusion criteria
Type of Study:
Observational
Study Design:
Observational Model: Case Control, Time Perspective: Prospective
Outcome Measure:
Different diseases will be analysed for the levels of DNA circulating in the blood
Outcome Description:
To determine what medical conditions and disease states might increase circulating DNA levels at a magnitude similar to whole body irradiation.
Outcome Time Frame:
blood will be tested up to 1 year after collection
Safety Issue:
No
Principal Investigator
Paul Okunieff, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Florida
Authority:
United States: Institutional Review Board
Study ID:
407-2012
NCT ID:
NCT01815996
Start Date:
October 2012
Completion Date:
September 2016
Related Keywords:
- Pregnancy
- Pulmonary Embolism
- Myocardial Infarction
- Autoimmune Disease
- Pregnancy
- pulmonary embolism
- myocardial infarction
- autoimmune disease
- healthy controls
- Autoimmune Diseases
- Embolism
- Infarction
- Myocardial Infarction
- Pulmonary Embolism
Name | Location |
Shands Davis Cancer Center |
Gainesville, Florida 32610 |